underlying BR homeostasis, particularly the upstream signals that regulate BR biosynthesis and inactivation. BR biosynthesis occurs through network pathways and basically is regulated at the transcriptional level of BR biosynthetic genes. When the BR signal is activated, BR-specific transcription factor, BZR1, inhibits transcription of BR biosynthetic genes through feedback downregulation mechanisms. Moreover, BR biosynthesis is also affected by other hormones such as auxin. This review focuses on recent progress in our understanding of the regulation of BR biosynthesis, with an emphasis on the transcriptional mechanisms that regulate this
I. INTRODUCTION
The degree of response to phytohormones is determined by the following two major factors: the sensitivity of the responsive tissues and the concentration of bioactive hormones in the specific tissues (Davies, 2004) . Numerous biochemical processes contribute to the availability of bioactive hormones, including de novo biosynthesis, conjugation with other compounds, and transport from other cells or sequestering organelles. Because plant hormones act at relatively low concentrations, it is important to understand the intricate mechanisms that affect the pool size of bioactive hormones. Brassinosteroids (BRs) are polyhydroxylated steroid hormones that regulate various aspects of plant growth and development, such as vascular system differentiation, cell division and elongation, and sex determination. As such, mutants defective in BR biosynthesis or signaling are dwarfed with short hypocotyls, short petioles, dark green leaves, and delayed senescence (Choe et al., 1998; Choe et al., 1999b; Choe et al., 2002; Li et al., 2001) . The severe phenotypes of the BR mutants coupled with the presence of low concentrations of BRs in all plants examined demonstrate that BRs are essential plant hormones (Makarevitch et al., 2012; Hartwig et al., 2011) .
BR biosynthetic pathways were initially elucidated by in vivo feeding tests of labeled precursors of brassinolide in periwinkle (Catharanthus roseus) cell lines . The pathways were later validated by analyzing the endogenous levels of BRs in BR-deficient mutants in the late 1990s Choe et al., 1999a; Choe et al., 1999b; Klahre et al., 1998) . These combined approaches led to the identification of the entire metabolic pathways underlying the biosynthesis and inactivation of BRs. An understanding of the metabolic pathways is important, because it establishes how plants achieve optimum tissue-specific concentrations of BRs at specific developmental stages. Furthermore, BRs are not transported long distances, but are used near the BR-synthesizing cells (Symons and Reid, 2004) . Thus, it is important to understand the spatial and temporal regulatory mechanisms underlying BR biosynthesis in the context of the demand for BRs during growth and development.
In general, BR homeostasis depends on the controlled expression of the BR biosynthetic genes by the nuclear transcription factor BRASSINAZOLE RESISITANT 1 (BZR1) and its homolog BRI1-EMS-SUPPRESSOR 1 (BES1)/BZR2. BZR1 plays a key role, not only as a transcriptional inducer, but also as a repressor (He et al., 2005; Wang et al., 2002) . When BR signaling is activated, an active form of BZR1 binds to the promoters of BR biosynthetic genes and represses their expression. Conversely, when cellular BR levels decline, BZR1 is transformed into an inactive form by phosphorylation via BR INSENSITIVE (BIN2). GSK1-like kinase and de-represses the expression of the biosynthetic genes. Auxin stimulates BR biosynthesis by inhibiting the binding of BZR1 to the DWF4 promoter (Chung et al., 2011) . In this review, we will survey recent advances made in elucidating the pathways that underlie BR biosynthesis, inactivation, and signal transduction. Readers are also referred to previous review papers for further information (Choe, 2006; Clouse, 2011; Kim and Wang, 2010) .
II. BRIEF UPDATE ON BR SIGNALING PATHWAYS
The BR metabolic pathways are tightly coupled with the subsequent signaling cascades. Thus, to achieve a comprehensive understanding of BR homeostasis, it is important to have a current view of BR signaling pathways. BR signaling starts with the binding of bioactive BRs, e.g., brassinolide, to an island domain of a plasma membrane-localized receptor kinase, BRI1 (Figure 1 ). Auto-and transphosphorylation events between BRI1 and its co-receptor BRI1-Associated-Kinase1 (BAK1) cause the plasma membrane-localized inhibitor, BKI, to disassociate from BRI1 (Karlova et al., 2006; Oh et al., 2009; Wang et al., 2008) . BR-Signaling Kinases (BSKs) and Constitutive Differential Growth 1 (CDG1) transmit the BR signal and activate a protein phosphatase, BRI1 suppressor 1 (BSU1) (Tang et al., 2008; Kim et al., 2009; Kim et al., 2011) . Although BSKs and CDG1 do not possess transmembrane domains, they are palmitoylated and anchored in the plasma membranes . BSU1 dephosphorylates the Tyr200 residue of a component that negatively regulates BR signaling, BIN2 (Brassinosteroid insensitive 2) ) (Mora-Garcia et al., 2004 . Dephosphorylated BIN2 is inactive and is degraded by the 26S proteasome, as demonstrated by the finding that treatment with a proteasome inhibitor, MG132, caused BIN2 to accumulate (Peng et al., 2008) . However, when BR signaling is not activated, BZR1 and BES1 are phosphorylated and trapped by 14-3-3 proteins and remain outside the nucleus (Gampala et al., 2007; Ryu et al., 2007; Ryu et al., 2010) . Alternatively, phosphorylated BZR1 inside the nucleus binds inefficiently to the promoter DNA of its target genes . The reactivation of phosphorylated BZR1 is mediated by dephosphorylation through PP2A-type protein phosphatases (Tang et al., 2011) .
Research on BR signaling helped pioneer the related field of subcellular targeting of proteins. An analysis of the suppressor mutants of bri1-5 revealed an endoplasmic reticulum-associated degradation (ERAD) system that is an important component of protein quality control (Hong et al., 2008; Su et al., 2011) . Moreover, BAK1 is also involved in the recognition of Pathogen Associated Molecular Patterns (PAMPs) when switching its interacting partner to FLS2 (Belkhadir et al., 2012; Albrecht et al., 2012; Chinchilla et al., 2007) . In addition, studies of a novel gain-of-function allele of BAK1, elg-D (elongated-D), revealed that the leucine-rich repeat region of BAK1 is essential for the activation of BL signaling and functions as a switch between the two pathways underlying BR signaling and pathogen recognition (Chung et al., 2012; Jaillais et al., 2011) .
FIG. 1. The brassinosteroid signaling pathway. In the absence of BL (BL-), BKI1, which is bound to CDG1 and BSKs on the cytoplasmic face, interacts with an inactive form of BRI1 to prevent BAK1 from binding to BRI1. A constitutively active protein kinase, BIN2, phosphorylates its substrates, BZR1 and BES1, which are BR-specific transcription factors. The phosphorylated forms of these substrates are expelled from the nucleus and retained by 14-3-3 proteins in the cytoplasm. Red lines ending in a perpendicular line indicate inactivation and green arrows indicate activation. In the presence of BL (BL+), BL binds to an island domain of the BRI1 receptor kinase, which induces the auto-and trans-phosphorylation of BKI1 and BAK1. Phosphorylated BKI1 dissociates from BRI1 and is retained by 14-3-3 proteins. BAK1 and BRI1 form heterodimers and sequential phosphorylation events transmit the signal via CDG1 and BSKs. Phosphorylated CDG1 and BSK1s are released from the BRI1 receptor and activate a protein phosphatase, BSU1. Activated BSU1 inhibits BIN2/DWF12 by dephosphorylating Tyr200 of BIN2. Freed from BIN2 inhibition, BZR1 and BES1 transcriptionally regulate their target genes. Depending on the context of the sequences near the BZR1 recognition element (BRRE), BZR1 and BES1 either induce or inhibit their target genes (color figure available online).
Previously, attempts were made to identify and explore the functions of BRs in various aspects of plant physiology. The IWS1 (Interact-With-Spt6), transcriptional regulator was involved in RNAPII recruitment and to interact with BES1 to activate BR-responsive genes . Also, BES1 interacts with the Jumonji-domain proteins, REF6 and ELF6, to regulate gene expression through histone modification (Yu et al., 2008) . BR controls male fertility by regulating several key anther and pollen development genes . Similarly, BRs were shown to control sex determination in maize by studies of the na1 mutant, which lacks 5α-steroid reductase (Hartwig et al., 2011) . Additionally, SDG725, which encodes a H3K36 methyltransferase, plays an important role in the regulation of BRrelated genes in Oryza sativa (rice; Sui et al., 2012) . Recently, a genome-wide ChIP-chip analysis using a BZR1-CFP transgenic line identified 953 BRBT (BR Response BZR1 Target) genes and proposed the existence of BZR1-mediated crosstalk between BR and other signaling pathways (Sun et al., 2010) . A similar approach using an anti-BES1 antibody identified 250 genes as direct targets of BES1 (Yu et al., 2011) . The identification of the target genes of BZR1 and BES1 provided insight into the interactions between BRs and other signaling mechanisms.
Progress has been made in our understanding of the interactions between BRs and other hormones. BIN2 can directly interact with ARF2, a repressor of auxin signaling, leading to the activation of the auxin response (Vert et al., 2008) . Gibberellic acid (GA) and BR pathways appear to interact with each other. DELLA proteins, which are degraded in response to GA, were shown to bind BZR1 and thereby prevent BZR1 from binding to its target DNA, thus forming a critical link between BZR1 and the photomorphogenic regulatory system (Bai et al., 2012) . Furthermore, emerging evidence suggests that BRs also interact with jasmonic acid (JA). The finding that pcs1, a leaky mutation of DWF4, suppresses coi1, the mutant gene involved in JA signaling, suggested that BR has a negative effect on JA signaling (Ren et al., 2009) . Thereafter, dwf4-5D, an activation-tagged mutant exhibiting reduced sensitivity to JA, was isolated and it was proposed that BR enhances JA signaling by modulating JIN1/MYC2 transcription . Moreover, this BR-mediated activation of JA may trigger susceptibility to Pseudomonas syringae infection, and thereby fine-tune the balance between growth and defense mechanisms .
III. CHARACTERISTICS OF BR BIOSYNTHETIC
PATHWAYS: A NETWORK A combination of genetics and analytical biochemistry approaches has elucidated the BR biosynthetic pathways; now, only the genes encoding a few of the catalytic enzymes remain to be identified. Initially, the BR biosynthetic pathways were thought to be based on the following two parallel pathways: the early C-6 and late C-6 oxidation pathways . Later, based on the finding that DWF4 can act on multiple biosynthetic intermediates in the upstream steps, the pathways can bifurcate at campesterol to establish an early C-22 hydroxylation pathway (Figure 2 , shaded in yellow) (Choe et al., 2001; Fujioka and Yokota, 2003) . Overall, the brassinolide biosynthetic pathways are triterpenoid pathways. Squalene is cyclized FIG. 2 . Illustration of networked pathways for brassinosteroid biosynthesis. Starting with campesterol (CR) as the primary precursor, the three major pathways of BR biosynthesis are shaded in different colors. The early C-22 oxidation pathway, highlighted in yellow, hydroxylates C-22 via the action of DWF4 and thus is campestanol-independent. There are two campestanol (CN)-dependent pathways: the early and late C-6 oxidation routes. The early C-6 oxidation route undergoes C-6 oxidation ahead of C-22 oxidation (in green). The late C-6 oxidation pathway hydroxylates C-22 ahead of C-6 oxidation (in purple). Dotted arrows indicate more than one enzymatic step (color figure available online).
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Y. CHUNG AND S. CHOE into cycloartenol through a plant-specific enzyme system (Hartmann, 1998) . Plant sterols with different alkyl substituents at C-24, such as cholesterol (C27, a total of 27 carbon atoms in the compound), campesterol (C28), and sitosterol (C29) can be used as precursors of 28-norbrassinolide, brassinolide and 28-homobrassinolide (Fujioka and Yokota, 2003) .
In the C28 pathway, campesterol (CR) can be modified by the following two different enzymes: DWF4/CYP90B1, which functions as a C-22 hydroxylase, and CPD/CYP90A1, which functions as a C-3 dehydrogenase (Figure 2 ). It appears that, depending on the availability of substrates and enzymes, the biosynthetic pathways proceed to either DWF4-or CPD-mediated reactions without strict order or reactions between the two enzymes. DWF4 can act on multiple substrates, including CR, 4-en-3-one, 3-one, CN, and 6-oxoCS, to form early C-22 oxidation pathways (Figure 2 , shaded in yellow). Similarly, CPD can metabolize CR, 22-OHCR, and 22,23-dihydroxyCR and constitute multiple parallel pathways ( Figure 2 ). Once CR is hydroxylated by DWF4, the intermediates are further modified and merged into the late C-6 oxidation pathways ( Figure 2 , shaded in purple). It was initially claimed that CYP90A1/CPD encoded C-23 hydroxylase in that it converts TE to CS based on the physiological feeding test (Szekeres et al., 1996) . However, CYP90A1/CPD has been newly found to participate in C-3 oxidation in the recent study based on GC-MS and genetic analysis (Ohnishi et al., 2012) . The conversion pathway of 6-deoxoTE to 6-deoxo3DT and 6-deoxoCT to (22S)-22-hydroxycampestan-3-one are also catalyzed by CYP90A1/CPD. 24-OHCR was greatly accumulated and the level of 6-deoxo3DT and 6-deoxoCS were reduced in cpd knock out mutant. By this research, campestanolindependent pathway was highlighted as predominant route in BR biosynthesis. Furthermore, CYP90C1/ROT3 and CYP90D1, which are phylogenetically close, are shown to have redundant function as C-23 hydroxylases. This suggested new BR pathway as a shortcut by converting (22S,24R)-22-hydroxy-ergost-4-en-3-one, (22S,24R)-22-hydroxy-5a-ergostan-3-one and 3-epi-6-deoxocathasterone to their C-23 hydroxylated forms (Bishop, 2007) .
In the early C-6 oxidation pathway, C-6 oxidation takes place before DWF4-mediated C-22 hydroxylation (Figure 2 , shaded in green). Arabidopsis CYP85A1 and CYP85A2 were found to catalyze the C-6 oxidation reaction. Both of these enzymes convert 6-deoxoTY and 6-deoxoCS into TY and CS, respectively . CYP85A2 was shown to catalyze two consecutive reactions, converting 6-deoxoTY to BL via CS. These two enzymes seem to act only on downstream compounds, such as 6-deoxoTY and 6-deoxoCS. An analysis of endogenous BR levels in the cyp85a1 cyp85a2 double mutant revealed the accumulation of 6-oxo CN, which is made early in the BR pathway, after a C-6 oxidation reaction (Table 1) ; therefore, the currently unidentified enzyme might act on an upstream compound CN to convert it into 6-oxoCN instead of CYP85A .
The CYP85A2-mediated BL synthase reaction seems to take place only in dicotyledonous plants. An analysis of rice plants did not reveal detectable levels of BL, even in a BR accumulating plant such as the bri1 mutant (Yamamuro et al., 2000) . More convincingly, monocotyledonous plants, including rice, have only one copy of the CYP85A gene, whereas dicotyledonous plants have more than two . Thus, CS is likely an end product in rice .
Although genetic and biochemical approaches have identified many of the enzymes involved in BR biosynthesis, several (Choe et al., 1999b) Values represent concentrations in ng/g f.w.
Relative levels of endogenous BRs in the late C-6 oxidation pathway. To identify the rate-limiting step in the pathways, the endogenous levels of BR biosynthetic intermediates were drawn to scale. In the leftmost diagram, the names of BR biosynthetic intermediates are listed in order of biosynthetic steps. Enzyme names and Steady State Conversion Index (SSCI) values are given to the right of the arrows. The length of the horizontal bars represents the relative level of endogenous BR intermediates. The bars for 24-MC, campesterol, and campestanol were downscaled 50-, 300-, and 10-fold, respectively, to fit within the available space. The endogenous levels of BRs shown in the figure are the averages of values reported in four papers, i.e. (Choe et al., 2001; Choe et al., 2002; Noguchi et al., 1999; Fujioka et al., 2002). remain to be determined. In Pisum sativum (pea), 6-deoxoTY is converted into 6-deoxoCS by PsDDWF1 and a supplementary factor, Pra2 (Kang et al., 2001) . However, the Arabidopsis C-2 hydroxylase has not been identified yet. Further phylogenetic analyses in combination with biochemical genetics may reveal the identity of this enzyme in Arabidopsis in the near future.
IV. DWF4 IS A RATE-DETERMINING STEP IN BR PRODUCTION
The identification of the rate-determining step in a biosynthetic pathway enhances our understanding of the characteristic metabolic flux of the pathway. To visually reveal the steps that are bottlenecked in the flux of the BR pathway, we illustrated the relative levels of endogenous BRs based on published data ( Figure 3) . As an index of flux at each enzymatic step, we calculated the ratio of biosynthetic intermediates, [substrate] vs. [product] , and dubbed the values the steady state conversion index (SSCI). As shown in Figure 3 , the SSCI for DWF4 was 195, being the greatest among the steps examined; the SSCIs for DET2, ROT3, CPD, CYP85A1, and CYP85A2 were 39, 26, 0.06, 13, and 1.5, respectively. Furthermore, the SSCI for DWF4 in the early C-22 hydroxylation pathways was 51,384 (Figure 4) , which was even greater than that in the late C-6 oxidation pathways (195; Figure 3) . A greater SSCI value can be interpreted in two alternative ways. First, the reaction rate of the concerned enzymatic step may be low. Second, the reaction rate downstream of the concerned step may be so great that the intermediates are rapidly metabolized.
In either case, the finding that the SSCI value for DWF4 was greatest suggests that the DWF4-mediated step represents a bottleneck and thus serves as a rate-determining step of the entire network of biosynthetic pathways.
The catalytic activity of DWF4 can be modulated by the quantity of enzyme present, post-translational modification (e.g., phosphorylation), or steric regulation by the substrate or end product. A study using the DWF4pro:GUS line supported the idea that the activity of DWF4 is regulated by modulating the quantity of enzyme present. A histochemical analysis using the promoter-reporter line showed that the steady state levels of DWF4 transcript were only marginal in different tissues of Arabidopsis plants, and that only the tissues undergoing active cell division and elongation, such as the root tip, axillary buds, and emerging leaves expressed DWF4 in a tissue-specific manner (Kim et al., 2006) . In addition, an examination of the endogenous levels of the biosynthetic intermediates revealed a positive correlation between the DWF4-expressing tissues and the abundance of bioactive BRs.
Furthermore, the phenotype of DWF4 overexpression (DWF4-OX) lines clearly suggested that DWF4 transcription is tightly regulated (Choe et al., 2001) . The DWF4-OX lines displayed the morphology of plants subjected to repetitive BR treatment; i.e., long hypocotyls and tall stature at maturity. In addition, the overexpression lines produced excess seeds due to the increased number of pedicels per plants (Choe et al., 2001) . Considering the high SSCI of DWF4, the spatially limited expression pattern of this protein, and the enrichment of In the leftmost diagram, the names of BR biosynthetic intermediates are listed in order of biosynthetic steps. Enzyme names and Steady State Conversion Index (SSCI) values are given to the right of the arrows, where available. The length of bars for 24-MC and campesterol were downscaled 50-and 500-fold to fit within the available space . Again, the DWF4-catalyzed reaction emerges as the rate-limiting step.
bioactive BRs in DWF4-expressing tissues, it is likely that DWF4 activity, which is primarily regulated at the transcriptional level, determines the overall flux of the BR biosynthetic pathways.
V. REGULATION OF BR BIOSYNTHESIS
BR biosynthesis is regulated by two major mechanisms. First, the level of endogenous BRs is regulated by modulating the transcriptional activity of the biosynthetic genes. Second, BRs are inactivated, resulting in reduced levels of bioactive BRs. As mentioned earlier, research on BR biosynthetic pathways has a longer history than that on the corresponding signaling pathway. However, in contrast to the flurry of results pertaining to the signaling pathway, until recently, little was known about the regulation of BR biosynthesis. An analysis of mutants defective in BR biosynthesis revealed many previously unknown mechanisms of regulation.
A. Mutants in BR Biosynthesis
Maintenance of an optimal level of BRs is critical for the proper control of plant growth and development. BR-deficient mutants display a characteristic dwarf phenotype, such as short hypocotyls during the seedling stage and short stature at maturity, reduced fertility, and de-etiolation in the dark. Conversely, plants that have elevated levels of BRs show morphological aberrations, such as slender roots and wavy petioles and hypocotyls. The dwarfism of BR-related mutants can be caused by two factors. One is a defect in endogenous BR levels due to a lack of BR biosynthetic enzymes. In such cases, the biosynthetic product of the enzyme altered by the mutant gene decreases significantly, whereas the precursor of the mutated enzyme accumulates (Table 1). The other is a defect in signaling components. Defects in BR recognition and signal transduction, and the abnormal activation or deactivation of signal components can disrupt the BR responses and homeostasis (Table 2) . Some signaling defects activate BIN2, which results in the phosphorylation of BZR1, Values represent concentrations in ng/g f.w.
leading to the de-repression of genes involved in the biosynthesis of endogenous BRs. As illustrated by the phenotypes of those mutants, maintaining optimal levels of BRs by feedback regulation is a central mechanism in plants. BR biosynthesis and the alleles of BR biosynthetic mutants are summarized in two reviews Choe, 2006) .
B. The Regulation of BR Biosynthesis at the Transcriptional Level
The expression of BR biosynthetic genes is primarily regulated at the transcriptional level via transcriptional repressors and activators. A biochemical analysis of bacterially expressed DWF4 revealed that DWF4 is not subject to allosteric regulation; the conversion rate of CR to 22-OHCR was not affected by the presence of bioactive end products, including CS and BL (Fujita et al., 2006) . Instead, the transcript levels of DWF4 and CPD were significantly downregulated by negative feedback. BZR1 is thought to be the transcriptional regulator of this process.
DWF4 is the most sensitive gene to exogenous treatment with epi-BL or a BR biosynthesis inhibitor, brassinazole (Brz). BL is the final product of BR biosynthesis and is the most active BR in the BR signaling pathway. To maintain BR homeostasis, the level of mRNAs corresponding to BR biosynthetic genes should increase or decrease to modulate the BR level. In the case of DWF4, DWF4 mRNA accumulated in BR signaling deficient mutants as well as upon treatment with a BR biosynthesis inhibitor such as Brz. Conversely, treatment with epi-BL rapidly downregulated the level of DWF4 transcript. However, not all of the BR biosynthetic genes are regulated by this mechanism. Whereas DWF4, CPD, BR6ox1, and ROT3 mRNA exhibit quick responses to both epi-BL and Brz, DET2 responds only to Brz . The sterol biosynthetic genes, STEROL METHYLTRANSFERASE2 (SMT2) and DWARF1 (DWF1), respond neither to Brz nor to BL, while only FACKEL (FK) is upregulated by Brz. Interestingly, the expression of all of these genes, except DWF4, is not affected by BL and Brz in the bri1-401 background, suggesting that feedback regulation requires functional BRI1 . Nevertheless, the normal response of DWF4 in the bri loss-of-function background to BL and Brz suggests that hitherto unidentified mechanisms exist for regulating DWF4 transcription Bancos et al., 2002) .
C. BZR1 Functions Both as a Transcriptional Inducer and a Feedback Repressor
In the transcriptional regulation of BR biosynthetic genes, such as DWF4 and CPD, the activity of BZR1 is primarily responsible for the feedback regulation Kim et al., 2006) . When activated, dephosphorylated forms of BZR1 bind to the BR-responsive element (BRRE, CGTG[TC]G) of the promoter sequence of DWF4 and CPD to repress their transcription (He et al. 2005) . In addition, treatment with a eukaryotic translational inhibitor, cycloheximide (CHX), decreased CPD, but increased DWF4 expression, suggesting that transcription of CPD is controlled by an activator, whereas DWF4 transcription is primarily regulated by an inhibitory mechanism (Kim et al., 2006) . In general, transcriptional regulation is primarily based on BZR1-mediated feedback mechanisms, with supplemental regulation by other transcription regulators.
The bzr1-1D mutant, a gain of function allele of BZR1, exhibits a semi-dwarf phenotype due to repression of DWF4 and CPD and thus has decreased endogenous levels of BRs. Although BES1 also represses DWF4 and CPD to attenuate BR responses (Yu et al., 2011) , bes1-D does not display the semidwarf phenotype of bzr1-1D, but rather has a phenotype closer to that of constitutive BR response mutants. The level of BR intermediates significantly decreased in bzr1-1D compared to the wild type; strikingly, the level of CS decreased by more than 24-fold (Table 2) . Even though the endogenous BR content in bes1-D has not been reported, it seems likely that BES1 controls the expression of genes acting downstream in the signaling pathways, leaving BZR1 as a feedback regulator of the BR biosynthetic genes.
elg-D is a gain-of-function allele possessing an EMS mutation in the third leucine-rich repeat domain of the BR coreceptor BAK1 (Chung et al., 2012; Jaillais et al., 2011; Whippo and Hangarter, 2005) . The elg-D mutation suppresses the dwarf phenotype of the weak bri1-5 mutant due to the constitutive activation of BR signaling. As a result, the feedback downregulation of BR biosynthetic genes is functional in the bri1-5 elg-D double mutant, and the endogenous BR levels are greatly reduced (Chung et al., 2012) . Thus, the activation of BR signaling decreases BR biosynthesis mainly through BZR1.
D. Auxin Stimulates BR Biosynthesis
Auxin stimulates DWF4 expression in Arabidopsis (Chung et al., 2011) . Physiological studies using a DWF4pro:GUS transgenic line revealed that synthetic auxin 2, 4-dichlorophenoxyacetic acid (2,4-D) strongly induced DWF4 expression, especially in the root tips. DWF4 induction is independent of BR signaling, but requires auxin signaling. In both BLtreated and untreated conditions, BZR1 binds to the BRRE in the DWF4 promoter, but its binding was attenuated by auxin. In the DWF4 promoter, the following cognate sequences for transcription factors are present: three BRRE motifs (Chung et al., 2011) , one Aux/IAA response element (Aux/IAA-RE, TGTCTC) (Ulmasov et al., 1997a; Ulmasov et al., 1997b) , and one Aux/IAA-RE-like element (TGTGCTC) (Hagen and Guilfoyle, 2002) .
One of the auxin response factors, ARF7, was found to directly bind to the DWF4 promoter in a chromatin immunoprecipitation (ChIP) assay (Chung et al., 2011) . Considering the contribution of transcription factors such as BZR1 and ARF7, we present a regulatory model for the auxin-stimulated biosynthesis of BRs ( Figure 5 ). In the presence of high levels of auxin, an auxin-specific inhibitor, Aux/IAA, is degraded and releases an ARF, which is able to bind to the DWF4 promoter and induce transcription. In this situation, BZR1 may relinquish its occupation of the binding site of ARF7 or other factors. Interestingly, the auxin-mediated induction of DWF4 expression was masked by CHX treatment, indicating that de novo synthesis of another transcription factor is required to induce DWF4 in an auxindependent manner. Similarly, the auxin receptor triple mutant, tir1-1 afb1-3 afb2-3, failed to induce DWF4 expression relative FIG. 5 . Proposed model for auxin-stimulated BR biosynthesis. Repression of DWF4 by BR-mediated feedback downregulation mechanisms (top) and induction of DWF4 in the presence of auxin (bottom). When cellular auxin levels are low, BZR1 binds to the DWF4 promoter to repress DWF4 expression. ARF, which forms a herterodimer with Aux/IAA, also binds to and represses the DWF4 promoter. When the auxin level increases, the Aux/IAA repressor is degraded. Freed ARF may activate the expression of a transcription factor, X, which is synthesized de novo. Factor X binds to the DWF4 promoter alone or as a heterodimer with other factors to activate the expression of DWF4 (color figure available online).
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to the wild type, indicating that the auxin-mediated induction of DWF4 occurs via a auxin signaling pathway.
The endogenous levels of BR intermediates, especially of the products formed by the action of DWF4, were dramatically increased by 2,4-D treatment. Whereas the proposed model (Figure 5) can explain the synergistic effect of auxin and BRs, it does not reveal how the inhibitory protein BZR1 is released from binding when auxin signaling is activated.
The auxin-mediated stimulation of DWF4 expression is also supported by experiments conducted at a high temperature (29
• C) . Using DWF4pro:GUS lines, it was shown that DWF4 was strongly induced when the seedlings were transferred from ambient to high temperatures. Hypocotyl elongation at high temperatures is known to be an auxin-specific response, as auxin biosynthesis and transportation are stimulated at high temperatures (Gray et al., 1998) . This hypocotyl elongation was inhibited in a BR biosynthetic mutant background, implying that temperature-dependent hypocotyl elongation may require increased levels of BR biosynthesis and that BR is necessary for hypocotyl elongation in high temperatures (Nemhauser et al., 2006; .
The results of a microarray analysis suggested that auxinresponse genes are not induced as expected when plants were treated with both auxin and the BR biosynthesis inhibitor, Brz (Chung et al. 2011) . This implies that auxin may regulate its target genes indirectly through BRs, which are synthesized de novo under the direction of auxin. Auxin and BRs regulate the expression of separate sets of genes; however, a significant portion of genes previously known to be auxin-responsive should be re-defined as BR-responsive genes (Chung et al., 2011) .
Although the effect of auxin on the stimulation of DWF4 expression is mostly independent of BR signaling components, BIN2 represents an exception. Auxin induces lateral root development, and BIN2 synergistically enhances this response. The number of lateral roots was greater in the bin2/dwf12-1D mutant than in the wild type . Furthermore, it was suggested that BIN2 is a target of regulation when ABA inhibits BR signaling (Zhang et al., 2009) . In the presence of lithium ion, which is a specific inhibitor of BIN2, the ABA-mediated inhibition of BR signaling was greatly attenuated (Zhang et al., 2009 ). Therefore, it is possible that BIN2 plays a central role not only in BR signaling, but also in interactions with other hormones.
Furthermore, BR biosynthesis is also regulated through the induction of CPD. BRX (BREVIS RADIX), an auxin-response transcription factor, is found to upregulate CPD transcription (Mouchel et al., 2006) . In a microarray analysis, treatment of brx S , the loss-of-function allele of BRX, with BL restored most of the gene expression pattern to the Sav-0 wild type. Specifically, the CPD transcript level was significantly downregulated in the brx S microarray analysis, indicating that BRX targets CPD to control BR biosynthesis. BRX is transcriptionally induced by auxin treatment and downregulated by BL, suggesting that BRX contributes to BR homeostasis by maintaining a feedback loop.
E. Transcriptional Regulators That Affect BR Biosynthesis
A screen of T-DNA activation tagging lines of Arabidopsis identified a positive regulator of BR biosynthesis. Guo et al. (2010) reported that tcp1-1D partially suppressed the dwarfism of bri1-5 (Figure 6 ). However, tcp1-1D failed to rescue severe alleles of bri1and dwf4. Although TCP1 directly binds to the DWF4 promoter, a typical binding motif of rice class I or II TCPs was not present in the DWF4 promoter, suggesting that TCP1 might regulate DWF4 expression by assisting other transcription factors or binding sequences. tcp1-1D exhibited increased levels of endogenous BRs and its repressor variant, TCP1-SRDX, greatly reduced the concentration of BR intermediates, especially 6-deoxoCT and (22S)-22-hydroxy-campesterol, which are the products of the DWF4-catalyzed reaction.
The ces-D mutant was identified based on its typical BRoverexpressing phenotype (Poppenberger et al., 2011) . CESTA encodes a bHLH transcription factor that is directly targeted to CPD via binding to the G-box (CACGTG) in the promoter. Interestingly, CESTA is co-localized with its close homologs, BEE1 and BEE3 (Friedrichsen et al., 2002) .
F. BR Biosynthesis Inhibitors
Although many Arabidopsis BR mutants were identified based on their obvious dwarf phenotypes (Choe, 2004) , it is difficult to screen for these defects in crop plants like Zea mays (maize) or Sorghum bicolor (sorghum) (Salas Fernandez et al., 2009) . Studies on BRs for such plants are in their early stages partly because their BR-deficient phenotypes are unknown. For this reason, BR biosynthesis inhibitors can be useful tools for investigating the role of BRs.
Brz, a triazole-type compound, has been used as a strong BR biosynthesis inhibitor, with few secondary effects on GA levels or activity ( Figure 6 ) (Asami et al., 2000) . DWF4, a steroid C-22 hydroxylase, was found to be a target of Brz. Later, Sekimata et al. (2001) characterized Brz2001, a more specific BR biosynthesis inhibitor (Sekimata et al., 2001) . Despite the strong specificity of Brz and Brz2001, the relatively high cost of these compounds has limited their application in agricultural and large-scale field work. As an alternative, another triazolederived and commercially available compound called Propiconazol (Pcz) was reported to be applicable to both Arabidopsis and maize (Hartwig et al., 2012) . Pcz could be used to decipher BR biosynthetic pathways in economically important plants.
VI. BR INACTIVATION BY MODIFICATION
BR metabolism and catabolism are two important processes contributing to the homeostasis of cellular BR levels. Although numerous BR conjugates and metabolites have been isolated, only a few genes responsible for BR inactivation have been identified. BAS1 and its paralog SOB7/SHK1/CHIBI2 mediates C-26 hydroxylation, leading to BR inactivation (Turk et al., 2005; Nakamura et al., 2005; Neff et al., 1999; Takahashi et al., 406 Y. CHUNG AND S. CHOE FIG. 6 . The transcriptional regulation of brassinosteroid biosynthetic genes, DWF4 and CPD. DWF4 transcription is repressed by active BZR1, but induced by the TCP transcription factor. ARFs likely control DWF4 induction via auxin-dependent pathways. CPD transcription is activated by BRX and CES transcription factors. Biosynthesized BL activates BZR1 through a BR signaling pathway, and activated BZR1 represses DWF4. In contrast, the TCP transcript level rises when BL signaling is switched on. DWF4 enzyme activity is inhibited by chemical inhibitors of BR action, such as Brz, Brz2001, and Pcz. Endogenous levels of bioactive BRs are also affected by deactivating enzymes, such as BAS1 (CYP734A1), SOB7 (CYP72C1), and acyltransferases, including BIA1/ABS1, PIZ, BAT1, and BEN1 (color figure available online).
2005). SOB7/SHK1/CHIBI2, a paralog of BAS1, remains to be characterized. Circumstantial evidence suggests that this protein favors upstream intermediates of the BR biosynthetic pathways as substrates (Thornton et al., 2010) .
Activation tagging mutagenesis of a weak bri1 allele, bri1-5, resulted in the identification of ben1-1D (bri1-5 enhanced 1-1dominant), which showed an enhanced bri1-5 phenotype (Yuan et al., 2007) . A search for similar sequences revealed that BEN1 shares similarities with a dihydroflavonol 4-reductase (DFR), suggesting that this protein exhibits reductase activity in BR inactivation pathways. BEN1 was transcriptionally induced by epi-BL, whereas BAS1 was downregulated in ben1-1D. The activation tagging phenotypes and sequence similarity suggest that BEN1 acts as an inactivating modifier of endogenous BRs. Profiles of endogenous BR levels in ben1-1D suggest that far downstream compounds, including TY, CS, and BL, are more likely targets than upstream compounds, such as 6-deoxoCT, 6-deoxoTE, and 6-deoxoTY.
Glycotransferases (GTs) are another group of enzymes associated with BR inactivation. GTs generally transfer the glycosyl donor groups to small molecular acceptors, such as BRs. UDPglucose:flavonol-3-O-glycoside-7-O-glucosyltransferase (UGT 73C6) was initially reported to mediate the biosynthesis of flavonol glycosides (Jones et al., 2003) and to catalyze the 23-O-glycosylation of CS and BL as part of the inactivation process (Poppenberger et al., 2005) . A close homolog, UGT73C5, also participates in BR inactivation reactions (Poppenberger et al., 2005) .
BRs are also inactivated by conjugation with a sulfate group. The Brassica napus sulfotransferases (BNST3 and BNST4) catalyze the O-sulfonation of BRs at C-22OH (Marsolais et al., 2007; Rouleau et al., 1999) . Later, AtST4a and AtST1, sulfotransferases with similar functions, were reported in Arabidopsis (Marsolais et al., 2007) .
Furthermore, it was reported that acylation of BRs could result in BR inactivation. A screen of Arabidopsis transgenic lines overexpressing full-length cDNAs (FOX-hunting lines) for mutants that phenocopy BR-deficient mutants yielded bia1-1D and bia1-2D (Roh et al., 2012) . BIA1 belongs to a family of proteins known as the BAHD acyltransferases. In the bia1-1D mutant, endogenous BR levels were significantly downregulated from 6-deoxoCT, indicating that BIA1 is involved in the inactivation of BRs. In addition, this enzyme was also studied independently under the name of ABS1 (Abnormal Shoot) . A biochemical assay is needed to verify that BIA1/ABS1 is indeed an acyltransferase.
An Arabidopsis full-length cDNA overexpressor gene hunting system (FOX hunting system) revealed another putative BAHD acyltransferase PIZZA (PIZ). The PIZ overexpression line displayed a typical dwarf phenotype (Schneider et al., 2012) . Microarray analysis revealed that PIZ overexpression upregulated the expression of BR biosynthetic genes, such as ROT3 and BR6ox, and downregulated that of BAS1. Furthermore, endogenous levels of 6-deoxoTY were downregulated in this line. It has been hypothesized that PIZ is an acyltransferase containing the HxxxDG motif in the transferase active site and the consensus DFGWGKP motif, which is conserved among transferases. Pending biochemical confirmation, BAHD acyltransferases, such as BIA1 and PIZ, might act redundantly in BR inactivation. Additionally, BAT1 (putative BR-related acyltransferase), a putative acyltransferase involved in BR inactivation, was identified by the FOX hunting technique (Choi et al., 2013) . The BAT1 overexpression line showed a substantial decrease in the level of 6-deoxoTY, TY, and 6-deoxoCS, and exhibited a growth-retarded phenotype, as seen in the BR dwarf mutants. Remarkably, BAT1 transcription is induced by auxin and is thus regulated by the auxin signaling pathway. This suggests that BAT1 might control BR homeostasis by mediating the cross-regulation between BR and auxin. Furthermore, the auxin-mediated stimulation of BR biosynthesis might be kept in balance by BAT1-mediated feedback inactivation.
VII. CONCLUSIONS
In this review, we summarized our current understanding of the regulatory mechanisms underlying BR biosynthesis. Disruption of BR homeostasis can bring about both growth retardation and altered patterns of development; therefore, the level of BRs in plants should be tightly controlled both positively and negatively by precise mechanisms. The feedback loop that regulates the expression of BR biosynthetic genes is primarily dependent on the repression and de-repression of transcription by BZR1. Moreover, BR homeostasis is primarily maintained by balancing the processes of BR inactivation and biosynthesis. Many of the transcriptional regulators of BR biosynthetic genes have been identified, with examples of positive regulators including TCP, CESTA, and BRX.
DWF4 is a key flux-determining enzyme that limits the endogenous level of BRs, and auxin stimulates DWF4 expression and accordingly increases the level of BRs via the auxin signaling pathway. In contrast, the stress hormone ABA inhibits the biosynthesis and signaling of BRs, possibly by mobilizing resources not towards growth but towards stress resistance. In Arabidopsis, the gene and corresponding protein underlying only one step in the BR biosynthetic pathways remain to be characterized. Future research should focus on isolating this unknown enzyme and deciphering the mechanisms of interaction between BRs and other hormones. A more detailed understanding of the mechanisms underlying the activity of BRs, especially in crop plants, should open up new opportunities to custom design plants for better performance in marginal lands and conditions.
